Cytochrome P450 2D6 polymorphism and drug utilization in patients with oral lichen planus

Acta Odontologica Scandinavica

Volumn 68, Issue 4, 2010, Pages 193-198

  Paulusová, Vladimíra ^a   Rösch, Christiane ^b   Dřízhal, Ivo ^a   Perlík, František ^b   Mašín, Vladimír ^c   Sukumar, Sujith ^a   Slezák, Radovan ^a   Slanař, Ondřej ^b  

^a University hospital of Hradec Kralove   (Czech Republic)

^b Department of Pharmacology   (United States)

^c CHARLES UNIVERSITY   (Czech Republic)

Author keywords

CYP2D6; Cytochrome P450; Genetic polymorphism; Oral lichen planus; Pharmacotherapy

Indexed keywords

CYTOCHROME P450 2D6;

AGED; ALLELE; ARTICLE; CASE CONTROL STUDY; DRUG UTILIZATION; ENZYMOLOGY; FEMALE; GENE DUPLICATION; GENETICS; HUMAN; LICHEN PLANUS; LIVER; MALE; METABOLISM; PATHOLOGY; POLYMERASE CHAIN REACTION; POLYPHARMACY; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

AGED; ALLELES; CASE-CONTROL STUDIES; CYTOCHROME P-450 CYP2D6; DRUG UTILIZATION; FEMALE; GENE DUPLICATION; HUMANS; LICHEN PLANUS, ORAL; LIVER; MALE; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYPHARMACY;

EID: 77953978650     PISSN: 00016357     EISSN: 15023850     Source Type: Journal    
DOI: 10.3109/00016351003636382     Document Type: Article

References (28)

1. Eisen D. Evaluating and treating patients with oral lichen planus. Dermatol Ther 2002;15:206-217
2. Dissemond J. Oral lichen planus: an overview. J Dermatol Treat 2004;15:136-140
3. Sugerman PB, Savage NW, Zhou XJ, Walsh L, Bigby M. Oral lichen planus. Clin Dermatol 2000;18:533-539
4. Axell T, Rundquist L. Oral lichen planus- - -a demographic study. Commun Dent Oral Epidemiol 1987;15:52-56
5. Silverman S Jr, Gorsky M, Lozada-Nur F. A prospective follow-up study of 570 patients with oral lichen planus: persistence, remission, and malignant association. Oral Surg Oral Med Oral Pathol 1985;60:30-34
6. Scully C, Beyli M, Ferreiro MC, Ficarra G, Gill Y, Griffiths M, et al. Update on oral lichen planus: Etiopathogenesis and management. Crit Rev Oral Biol Med 1998;9: 86-122.
7. Sugerman PB, Savage NW, Walsh LJ, Zhao ZZ, Zhou XJ, Khan A, et al. The pathogenesis of oral lichen planus. Crit Rev Oral Biol Med 2002;13:350-365
8. Gandolfo S, Carbone M, Carrozzo M, Gallo V. Oral lichen planus and hepatitis C virus (HCV) infection: is there a relationship? A report of 10 cases. J Oral Pathol Med 1994;23:119-122
9. Carrozzo M, Francia Di Celle P, Gandolfo S, Carbone M, Conrotto D, Fasano ME, et al. Increased frequency of HLADR 6 allele in Italien patients with hepatitis C virus-associated oral lichen planus. Br J Dermatol 2001;144:803-808
10. Lodig G, Porter SR. Hepatitis C virus infection and lichen planus: A short review. Oral Dis 1997;3:77-81.
11. Harden D, Skeleton H, Smith KJ. Lichen planus associated with hepatitis C virus: no viral transcripts are found in the lichen planus, and effective therapy for hepatitis C virus does not clear lichen planus. J Am Acad Dermatol 2003;48: 847-852
12. Ostman PO, Anneroth G, Skoglund A. Amalgam-associated oral lichenoid reactions. Clinical and histologic changes after removal of amalgam fillings Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1996;81:459-465
13. Laeijendecker R, Dekker SK, Burger PM, Mulder PG, Van Joost T, Neumann MH. Oral lichen planus and allergy to dental amalgam restorations. Arch Dermatol 2004;140: 1434-1438
14. Chaudhary S. Psychosocial stressors in oral lichen planus. Aust Dent J 2004;49:192-195
15. Ivanovski K, Nakova M, Warburton G, Pesevska S, Filipovska A, Nares S, et al. Psychological profile in oral lichen planus. J Clin Periodontol 2005;32:1034-1040
16. Firth NA, Reade PC. Angiotensin-converting enzyme inhibitors implicated in oral mucosal lichenoid reactions. Oral Surg Oral Med Oral Pathol 1989;67:41-44
17. Torpet LA, Kragelund C, Reibal J, Nauntofle B. Oral adverse drug reactions to cardiovascular drugs. Crit Rev Oral Biol Med 2004;15:28-46.
18. Kragerlund C, Thomsen CE, Bardka A, Pedersen AM, Nauntofte B, Rebel J, et al. Oral lichen planus and intake of drugs metabolized by polymorphic cytochrome P450 enzymes. Oral Dis 2003;9:177-187
19. Ingelman-Sundberg M, Johansson I, Persson I, Oscarson M, Hu Y, Bertilsson L, et al. Genetic polymorphism of cytochrome P450. Functional consequences and possible relationship to disease and alcohol toxicity. EXS 1994;71: 197-207.
20. Eisen D. The clinical features, malignant potential, and systemic assotiations of oral lichen planus. A study of 723 patients. J Am Acad Dermatol 2002;46:207-214
21. Kramer IR, Lucas RB, Pindborg JJ, Sobin LH. Definition of leukoplakia and related lesions: an aid to studies on oral precancer. Oral Surg Oral Med Oral Pathol 1978;46:518-523
22. Firth NA, Rich AM, Radden BG, Reade PC. Assessment of the value of immunofluorescence microscopy in the diagnosis of oral mucosal lichen planus. J Oral Pathol Med 1990;219:295-297
23. Hosokawa M, Masu S, Seiji M. Immunofluorescence studies on civatte bodies and dyskeratotic cells with anti-keratin antibody. Tohoku J Exp Med 1981;135:219-229
24. Buzkova H, Pechandova K, Slanar O, Perlik F. Frequency of single nucleotide polymorphisms of CYP2D6 in the Czech population. Cell Biochem Funct 2008;26:76-81.
25. Thorn JJ, Holmstrup P, Rindum J, Pindborg JJ. Course of various clinical forms of oral lichen planus. A prospective follow-up study of 611 patients. J Oral Pathol 1988;17:213-218
26. Robertson WD, Wray D. Ingestion of medication among patients with oral keratoses including lichen planus. Oral Surg Oral Med Oral Pathol 1992;74:183-185
27. Vondracek M, Xi Z, Larsson P, Baker V, Mace K, Pfeifer A, et al. Cytochrome P450 expression and related metabolism in human buccal mucosa. Carcinogenesis 2001;22:481-488
28. Ismail SB, Kumar SKS, Zain RB. Oral lichen planus and lichenoid reactions: ethiopathogenesis, diagnosis, management and malignant transformation. J Oral Sci 2007;49: 89-106.